Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Here are some general guidelines: Mild Deficiency: For those with a mild deficiency, a typical dosage might be 1,000 micrograms (mcg) once a week for several weeks
If this test is positive then it means you definitely have Pernicious Anaemia and you will need to continue your injections every 3 months
You wake up with more energy, less fatigue, and better focus
Your first appointment at our Weston clinic includes a consultation with a medical provider, a review of your health history, and diagnostic testing if needed
How many units of J0775 are billed per injection